The Vulpes Life Science Fund is rare co-investment fund that invests in undervalued companies that possess superior cutting-edge technology. The fund gives exposure to “best in class” technologies in the fields of regenerative medicine
We seek value investments in under priced UK biotech companies with strong under appreciated medical breakthroughs
We use a hands on activist approach to realise shareholder value and drive the business forward
We use long term patient capital to invest in businesses where we have high conviction
Tap into Vulpes' wealth of experience and expertise.